Zydus to soon start work on developing a vaccine for Delta variant

Also plans trials for children aged three years and above. Its needle-free injection is to be assembled in India

Apart from expecting to deliver 30-50 million doses of ZyCoV-D — India’s first vaccine for children aged 12-18 between October and January — Zydus Cadila will now start work on developing a version for the Delta variant and start trials on children aged three years and above.

Given that the delivery system of this vaccine is significantly more expensive, compared to the conventional injection-needle system, sources close to the development claimed that the price could be lower than Covaxin in the private market. 

ZyCoV-D will be delivered using a special injector that will use a specialised syringe or ‘applicator’. While